OTCMKTS:NXNN

Nexeon MedSystems Stock Forecast, Price & News

$0.55
0.00 (0.00 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.55
Now: $0.55
$0.55
50-Day Range
$0.16
MA: $0.35
$0.74
52-Week Range
$0.01
Now: $0.55
$1.25
VolumeN/A
Average Volume4,010 shs
Market Capitalization$1.12 million
P/E RatioN/A
Dividend YieldN/A
Beta12.71
Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.
Nexeon MedSystems logo

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:NXNN
CUSIPN/A
CIKN/A
Phone844-919-9990
Employees62
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$1.12 million
Next Earnings DateN/A
OptionableNot Optionable

Headlines

Nexeon MedSystems (OTCMKTS:NXNN) Trading Up 41.1%
March 27, 2021 |  americanbankingnews.com
NXNN Pre-Market Quotes
October 30, 2020 |  nasdaq.com
Nexeon MedSystems Inc.
April 25, 2020 |  www.barrons.com
NXNN.PK - Nexeon Medsystems Inc Profile | Reuters
October 21, 2019 |  www.reuters.com
Nexeon MedSystems Inc
March 19, 2019 |  www.bloomberg.com
See More Headlines

MarketRank

Overall MarketRank

0.73 out of 5 stars

Medical Sector

1245th out of 2,025 stocks

Electromedical Equipment Industry

34th out of 61 stocks

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -
$0.55
0.00 (0.00 %)
(As of 04/16/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NXNN News and Ratings via Email

Sign-up to receive the latest news and ratings for NXNN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Nexeon MedSystems (OTCMKTS:NXNN) Frequently Asked Questions

What stocks does MarketBeat like better than Nexeon MedSystems?

Wall Street analysts have given Nexeon MedSystems a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Nexeon MedSystems wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Nexeon MedSystems' earnings last quarter?

Nexeon MedSystems Inc. (OTCMKTS:NXNN) issued its quarterly earnings results on Monday, May, 21st. The company reported ($0.03) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.06) by $0.03. The business had revenue of $2.87 million for the quarter, compared to analyst estimates of $1.70 million.
View Nexeon MedSystems' earnings history
.

How has Nexeon MedSystems' stock been impacted by COVID-19?

Nexeon MedSystems' stock was trading at $0.51 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, NXNN shares have increased by 7.8% and is now trading at $0.55.
View which stocks have been most impacted by COVID-19
.

Who are Nexeon MedSystems' key executives?

Nexeon MedSystems' management team includes the following people:
  • Mr. William Rosellini M.B.A., M.S., J.D., MBA, Chairman & CEO (Age 41, Pay $2)
  • Mr. Christopher R. Miller, Chief Financial Officer (Age 51, Pay $131.75k)
  • Mr. Cathal Mc Fadden, VP of Operations
  • Dr. Austin Duke Ph.D., Chief Science Officer

Who are some of Nexeon MedSystems' key competitors?

What other stocks do shareholders of Nexeon MedSystems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nexeon MedSystems investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Fate Therapeutics (FATE), ObsEva (OBSV), Vaxart (VXRT), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AC Immune (ACIU), AcelRx Pharmaceuticals (ACRX) and Aldeyra Therapeutics (ALDX).

What is Nexeon MedSystems' stock symbol?

Nexeon MedSystems trades on the OTCMKTS under the ticker symbol "NXNN."

How do I buy shares of Nexeon MedSystems?

Shares of NXNN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nexeon MedSystems' stock price today?

One share of NXNN stock can currently be purchased for approximately $0.55.

How much money does Nexeon MedSystems make?

Nexeon MedSystems has a market capitalization of $1.12 million.

How many employees does Nexeon MedSystems have?

Nexeon MedSystems employs 62 workers across the globe.

What is Nexeon MedSystems' official website?

The official website for Nexeon MedSystems is www.nexeonmed.com.

Where are Nexeon MedSystems' headquarters?

Nexeon MedSystems is headquartered at 1910 PACIFIC AVENUE SUITE 20000, DALLAS TX, 75201.

How can I contact Nexeon MedSystems?

Nexeon MedSystems' mailing address is 1910 PACIFIC AVENUE SUITE 20000, DALLAS TX, 75201. The company can be reached via phone at 844-919-9990 or via email at [email protected]


This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected]beat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.